StockData
Acadia Pharmaceuticals Inc logo

Acadia Pharmaceuticals Inc (ACAD) income statement

ACADNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/3029% below fair value
$17.11−0.48 (-2.73%)

Close on Nov 20, 2026Market cap $2.95BP/E 7.7Yield –

See a number that looks wrong?